References

• AIDS Vu (2018). "Local Data: Texas ". Retrieved January 20, 2019, 2019, from https://aidsvu.org/state/texas/
• amfAR (2018). "Texas Opioid Epidemic." Opioid & Health Indicators Database. Retrieved January 20, 2019, 2019, from http://opioid.amfar.org/TX.
• Avert (2017). "Needle and Syringe Programmes (NSPS) for HIV Prevention ". Retrieved January 20, 2019, from https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes#footnote1_un8nkpn.
• Clasin, Giles. “Harm Reduction Centers Address a Different Model of Drug Use.” 2020. https://www.denvervoice.org/archive/2020/10/30/harm-reduction-centers-address-a-different-model-of-drug-use
• Centers for Disease Control and Prevention (2018). "Syringe Services Programs." Retrieved January 20, 2019, 2019, from https://www.cdc.gov/hiv/risk/ssps.html.
• Centers for Disease Control and Prevention (2018). ”Viral Hepatitis." Retrieved January 20, 2019, 2019, from https://www.cdc.gov/hepatitis/hcv/cfaq.htm
• Centers for Disease Control and Prevention (2015). ”Today’s Heroin Epidemic." Retrieved January 20, 2019, 2019, from https://www.cdc.gov/vitalsigns/heroin/index.html
• Drug Policy Alliance (2018). “Harm Reduction.” Retrieved January 24, 2019, from https://www.drugpolicy.org/issues/harm-reduction
• NIDA. (2018, May 29). Viral Hepatitis—A Very Real Consequence of Substance Use. Retrieved from https://www.drugabuse.gov/related-topics/viral-hepatitis-very-real-consequence-substance-use on 2019, January 28
• Nguyen, T. Q., Weir, B. W., Des Jarlais, D. C., Pinkerton, S. D., & Holtgrave, D. R. (2014). Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment. AIDS and behavior, 18(11), 2144-2155.